CD44 and pancreatic neoplasm: CD44 also promotes epithelial-mesenchymal transition (EMT) in many cancer types such as colon cancer, gastric cancer, pancreatic cancer, prostate cancer, liver cancer, and glioma by upregulating mesenchymal markers and downregulating epithelial markers.9